Transcription activator BRG1 is a protein that can be found in the nucleolus, SWI/SNF complex and membrane of cells. It is alternatively called SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4, SNF2-β and BRG1-associated factor 190A. In humans, BRG1 is an integral part of transcription by RNA polymerase II. Sequencing of BRG1 has shown it contains 5 types of conserved structural units: QLQ, bromo, helicase C-terminal, helicase ATP-binding and HSA domain. BRG1 binds with p53, transcription factor and RNA, and in addition, it is thought to be essential to organismal processes, for example, ATP-dependent chromatin remodeling, β-catenin-TCF complex assembly and positive regulation by host of viral transcription. It plays a role in the upregulation of pri-miRNA transcription by RNA polymerase II, transcription by RNA polymerase II and transcription, DNA-templated conversely. BRG1 also inhibits transcription, DNA-templated, transcription by RNA polymerase II and cell growth. BRG1 is the subject of extensive examination in part because of the fact that it is a member of the interleukin-7-mediated signaling pathway, positive regulation of Wnt signaling pathway and positive regulation of glucose mediated signaling pathway. BRG1 has been thought to be involved with essential functions like transcription corepressor, helicase and DNA-dependent ATPase activity. BRG1 is clinically significant because abnormalities in its function have been associated with diseases like rhabdoid tumor predisposition syndrome 2 (RTPS2) and coffin-siris syndrome 4 (CSS4). Coffin-Siris syndrome 4, an autosomal dominant inheritancedisorder characterized by microcephaly, hirsutism and short stature, has in specific been of interest to investigators.
We provide custom conjugation services for this antibody (e.g. labeling of BRG1 antibody with HRP). A list of available labels can be found in the table below: